FLT3 and acute myeloid leukemia: Similarly, high expression of SIRT7 (n = 57) also correlated with the overall survival in FLT3-wild-type AML patients and revealed a significantly better survival prognosis (p = 0.048) compared with patients with low SIRT7-expression (n = 25) (Supplementary Fig. 5B).